Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial

Summary:

The study aimed to compare survival outcomes among patients with metastatic, hormone-sensitive prostate cancer (MHSPC) based on the presence or absence of baseline bone pain at diagnosis.

Methodology:

The analysis used patient-level data from the SWOG-1216 trial, a phase 3, prospective randomized clinical trial. It included patients with newly diagnosed MHSPC from 248 academic and community centers across the US. The study involved patients who received androgen deprivation therapy (ADT) with orteronel or ADT with bicalutamide.

Findings:

Of the 1279 male study participants, 301 had baseline bone pain at diagnosis, while 896 did not. Patients with bone pain were found to have worse survival outcomes compared to those without bone pain. The data suggests that prioritizing these patients for enrollment in clinical trials and including bone pain in prognostic models of MHSPC may be beneficial.

Value and Practical Solutions:

The study’s findings can aid in patient counseling and prioritizing patients for clinical trials. It highlights the importance of considering bone pain in prognostic models of MHSPC. This information can be valuable for clinicians in guiding patient care and treatment decisions.

Trial Registration:

ClinicalTrials.gov Identifier: NCT01809691

Impact on Clinical Practice:

Clinical trials play a crucial role in developing effective treatments. The study’s results can potentially influence the inclusion of bone pain in prognostic models and patient prioritization for clinical trials. This can ultimately improve patient outcomes in MHSPC.

AI-Driven Solutions for Healthcare

DocSym Platform:

DocSym, an AI-driven platform, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians. This can help in extending the benefits of clinical trials into everyday medical practice.

Mobile Apps for Streamlining Operations:

Mobile apps supporting scheduling, monitoring treatments, and telemedicine can streamline operations in today’s healthcare environment. This can make it easier to manage patient care and expand services digitally, ultimately improving operational efficiency.

AI for Workflow Enhancement:

By utilizing AI, clinics can enhance their workflows, improve patient outcomes, and reduce paper routine. This can lead to more efficient and effective healthcare delivery.

Learn More:

Discover how AI can enhance clinical workflows and improve patient outcomes at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.